TD Asset Management’s Karuna Therapeutics, Inc. Common Stock KRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
|
|||||
|
2023
Q4 | $59.9M | Sell |
|
|||||
|
2023
Q3 | $38.5M | Buy |
|
|||||
|
2023
Q2 | $32.2M | Buy |
|
|||||
|
2023
Q1 | $25.4M | Buy |
|
|||||
|
2022
Q4 | $19.8M | Buy |
|
|||||
|
2022
Q3 | $17.2M | Buy |
|
|||||
|
2022
Q2 | $5.06M | Sell |
|
|||||
|
2022
Q1 | $5.89M | Sell |
|
|||||
|
2021
Q4 | $6.19M | Buy |
|
|||||
|
2021
Q3 | $4.88M | Buy |
|
|||||
|
2021
Q2 | $4.34M | Buy |
|
|||||
|
2021
Q1 | $4.45M | Buy |
|
|||||
|
2020
Q4 | $2.89M | Hold |
|
|||||
|
2020
Q3 | $2.2M | Buy |
|
|||||
|
2020
Q2 | $3M | Buy |
|
|||||
|
2020
Q1 | $1.9M | Sell |
|
|||||
|
2019
Q4 | $2.01M | Buy |
|
|||||
|
2019
Q3 | $374K | Buy |
|